AGTC Boosts AAV Manufacturing Productivity With Herpes Simplex Virus
By using the herpes simplex virus (HSV) as a helper for its adeno-associated viral (AAV) platform UF startup and UF Innovate | Sid Martin Biotech graduate Applied Genetic Technologies Corporation (AGTC) created AAVs that are more robust, purer and lower cost than any of the other methods. Its gene therapy program for X-linked retinitis pigmentosa […]
Dr. Barry Byrne Featured in Denison Magazine
Barry J. Byrne, M.D., Ph.D., director of the University of Florida Powell Gene Therapy Center, a professor in Pediatrics and Molecular Genetics & Microbiology, and the associate chair in Pediatrics at the University of Florida, is studying a variety of rare diseases with specific attention to developing therapies for inherited muscle disease. His development of the Powell Gene […]
UF Researcher Among 2020 ASGCT Award Recipients
Mavis Agbandje-McKenna, Ph.D., a professor of Biochemistry and Molecular Biology at the University of Florida College of Medicine, is among the winners of 2020 Outstanding Achievement Award (OAA) which recognizes an American Society of Gene & Cell Therapy (ASGCT) Member who has achieved a pioneering research success, specific high-impact accomplishment, or a lifetime of significant […]
RTP Gene Tech Firm Lands Deal Worth Up to $90M for 8 Nervous System Therapies
StrideBio, a life science startup focused on gene-editing technology, has a deal in place with a Massachusetts drug firm that could be worth nearly $90M plus royalties in years to come for rights to as many as eight potential gene-based therapies. Any developed drug would focus on the central nervous system and neuromuscular “targets,” StrideBio […]
U of Florida and Penn Ink Licensing Deal for Gene Therapy to Treat Retinal Disease (Tech Transfer eNews Blog)
Biotech company Ophthotech Corporation has entered into an exclusive global license agreement with the University of Florida Research Foundation (UFRF) and the University of Pennsylvania (Penn) to commercialize a treatment for a disease that causes blindness. The licensed technology is an adeno-associated virus (AAV) gene therapy to treat rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP), an […]
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania (Ophthotech)
Ophthotech Corporation announced that it has entered into an exclusive global license agreement with the University of Florida Research Foundation and the University of Pennsylvania (Penn) to develop and commercialize a novel adeno-associated virus (AAV) gene therapy product for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP), an orphan monogenic disease that is characterized […]